Epigenetic Reprogramming of HOXC10 in Endocrine-Resistant Breast Cancer

Science Translational Medicine - United States
doi 10.1126/scitranslmed.3008326
Full Text
Abstract

Available in full text

Categories
Medicine
Date
Authors
Publisher

American Association for the Advancement of Science (AAAS)

Related search

Epigenetic Reprogramming in Cancer

Science
MultidisciplinaryPhilosophy of ScienceHistory
2013English

S100β as a Serum Marker in Endocrine Resistant Breast Cancer

BMC Medicine
Medicine
2017English

Endocrine Therapy of Breast Cancer

2008English

Epigenetic Reprogramming and Emerging Epigenetic Therapies in CML

Frontiers in Cell and Developmental Biology
Developmental BiologyCell Biology
2019English

The Endocrine Prevention of Breast Cancer

British Journal of Cancer
Cancer ResearchOncology
1989English

Stromal Epigenetic Alterations Drive Metabolic and Neuroendocrine Prostate Cancer Reprogramming

Journal of Clinical Investigation
Medicine
2018English

Recent Advances in Endocrine Therapy of Breast Cancer

BMJ
1997English

Age Reprogramming and Epigenetic Rejuvenation

Epigenetics and Chromatin
GeneticsMolecular Biology
2018English

Transcription Factor-Mediated Epigenetic Reprogramming

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy